Retatrutide Injections *Maintenance* Complete Kit
Retatrutide 10mg vial is for monthly obesity and diabetes treatment through weekly injections, activating three metabolic pathways simultaneously.
- Retatrutide has produced substantial weight loss, with up to 24% reduction in Phase 2 trials and an average of 29% in Phase 3 trials.
- Retatrutide targets GLP-1, GIP, and glucagon receptors, activating all three pathways simultaneously.
Specifications
- Select Month:
- One Month (12mg), Two Months (12mg x 2 vials), Three Months (12mg x 3 vials)
AI Readiness
Good foundation, but some important product data is still missing.
78%